GLP-1R agonist 28
GLP-1R agonist 28 (Compound 19) is an orally active GLP-1R agonist. GLP-1R agonist 28 can increase insulin secretion and can be used in the research of GLP-1R-related diseases[1].
Product Specifications
UNSPSC
12352005
Target
GLP Receptor
Related Pathways
GPCR/G Protein
Field of Research
Metabolic Disease
Smiles
CC1=C(F)C(C)=CC(N2C(N3C=CN(C4=CC=C(N(C5CC5)N=C6)C6=C4F)C3=O)=C7[C@H](C)N(C(C8=CC9=NC(C%10CCOCC%10)=CC=C9N8[C@@]%11(C%12=NOC(N%12)=O)C[C@@H]%11C)=O)CCC7=N2)=C1
Molecular Formula
C47H45F2N11O5
Molecular Weight
881.93
References & Citations
[1]Bin Liang, et al. GLP-1R agonist and therapeutic method thereof. US12234236B1. 2025-02-25.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
